Severe or persistent symptoms may require medical attention and should be reported to your healthcare provider. Patients with certain health conditions or on specific medications should always talk with their healthcare provider before starting B12 injections to avoid interactions and ensure the treatment is appropriate
The Federal Food, Drug, and Cosmetic Act requires this notice
This makes it a potentially safer option for individuals concerned about insulin sensitivity or diabetes risk
[DOI] [PubMed] [Google Scholar] Andres 2004 Andres E, Loukili NH, Noel E, Kaltenbach G, Ben Abdelgheni M, Perrin AE, et al
Continued monitoring and formal pharmacovigilance would be appropriate if AOD-9604 were pursued clinically, but such monitoring does not exist for supplement use
Internal Code: BM-2-020 4-hydroxy-N'-(2-naphthylmethylene)benzohydrazide CAS 303760-60-3 Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc